OTC · Financial Statements

Lipella Pharmaceuticals Inc. (LIPO) Financial Statements

$0.07 OTC: LIPO Market Cap $300354

Lipella Pharmaceuticals Inc. most recently reported annual revenue of $1.0M, net profit of $-5.0M, revenue has compounded at 0.0% a year over the last five years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20202021202220232024
Revenue$1.0M$0$0$0$1.0M
Operating Profit$0$-2.0M$-3.0M$-5.0M$-5.0M
Net Profit$0$-2.0M$-3.0M$-5.0M$-5.0M
EPS$-0.23$-4.38$-5.12$-6.16$-4.79
Op Margin-5.9%-738.7%-1406.3%-1055.5%-947.2%

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$1.0M$2.0M$6.0M$4.0M$3.0M
Total Liabilities$0$1.0M$1.0M$0$1.0M
Cash$1.0M$1.0M$5.0M$3.0M$2.0M
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$0$-1.0M$-2.0M$-3.0M$-4.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$1.0M$4.0M$-2.0M$-1.0M
Free Cash Flow$0$-1.0M$-2.0M$-3.0M$-4.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.33
FCF Yield-785946.29%
Quick Ratio3.24
Interest Coverage0.00
Return 1Y-90.81%
Return 3Y-99.58%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
LIPO Overview LIPO Dividend Run Stock Screener